HIKMA FARMACEUTICA (PORTUGAL), S.A. secures contract for Acquisition Of Fulvestrant 250 Mg/5 Ml Sol Inj Ser 5 Ml Im - Cpa 961/2024

Portugal, Feb. 11 -- Portugal based HIKMA FARMACEUTICA (PORTUGAL), S.A. has secured contract from Unidade Local De Saude Do Alto Minho, Epe (Ulsam) for Acquisition Of Fulvestrant 250 Mg/5 Ml Sol Inj Ser 5 Ml Im - Cpa 961/2024. The value of the contract is worth 124000 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....